• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna, Inc. - Common Stock (NQ:MRNA)

    67.27 +7.52 (+12.59%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Moderna, Inc. - Common Stock

    < Previous 1 2
    ...
    9 10 11 12 13 14 15 16 17
    ...
    99 100 Next >
    News headline image
    Moderna Ignites Biotech Sector with Deal Talk Surge Amidst Broader Healthcare Woes
    October 30, 2025 – While the broader S&P 500 Healthcare sector navigated a day of mixed to negative performance, a singular beacon of optimism emerged from the biotechnology landscape today as Moderna... 
    Via MarketMinute
    Topics Intellectual Property Stocks
    News headline image
    Discover which S&P500 stocks are making waves on Thursday. ↗
    Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
    Via Chartmill
    News headline image
    Moderna Stock Rallies On Reports Of Company Entering Talks With A Drugmaker For A Potential Deal ↗
    According to a report from Seeking Alpha, citing Stat News, Moderna has held talks with at least one large drugmaker. 
    Via Stocktwits
    News headline image
    Thursday's session: top gainers and losers in the S&P500 index ↗
    Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session. 
    Via Chartmill
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
     
    Via Benzinga
    News headline image
    Is Moderna Inc Gaining or Losing Market Support? ↗
     
    Via Benzinga
    News headline image
    1 S&P 500 Stock to Research Further and 2 We Find Risky
    While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
    Via StockStory
    Topics Stocks
    News headline image
    Uncover the latest developments among S&P500 stocks in today's session. ↗
    Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session. 
    Via Chartmill
    News headline image
    Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
    As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Integer Holdings (ITGR) Shares Plunge 31.4% as Slower New Product Adoption and Revised Guidance Rock Investor Confidence
    New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares... 
    Via MarketMinute
    Topics Earnings Supply Chain
    News headline image
    Moderna Named a Top Employer by Science for Eleventh Consecutive Year
    Via ACCESS Newswire
    News headline image
    Moderna Stops CMV Program As Vaccine Falls Short In Preventing Infection ↗
    Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and financial guidance. 
    Via Benzinga
    News headline image
    Moderna Topples, Threatening Its 50-Day Line, After A Key Vaccine Bites The Dust ↗
    The company is scrapping its study in congenital CMV after the vaccine proved just 6% to 23% effective. 
    Via Investor's Business Daily
    News headline image
    Wondering what's happening in today's S&P500 pre-market session? ↗
    As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment. 
    Via Chartmill
    News headline image
    Moderna to Host Investor Event - Analyst Day
    Via ACCESS Newswire
    News headline image
    Moderna Stock Slides After-Hours On CMV Vaccine Failure In Phase 3 Trial — Retail Traders Warn Of ‘Endless’ Cash Burn ↗
    The biotech will continue testing the vaccine in bone marrow transplant patients, where CMV reactivation can cause serious complications, and said no safety concerns were identified. 
    Via Stocktwits
    News headline image
    What's going on in today's after hours session: S&P500 movers ↗
    Discover the top S&P500 movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    News headline image
    Global Economic Freedom in Retreat: A Four-Year Decline Signals Looming Market Shifts
    Washington D.C., October 22, 2025 – The world stands at a critical juncture as the 2025 Economic Freedom of the World index, prominently released by the Fraser Institute in collaboration with the Cato... 
    Via MarketMinute
    Topics Bonds Brexit Economy
    News headline image
    Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
    Via ACCESS Newswire
    News headline image
    Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why. ↗
    The biotech's innovative qualities will come in handy. 
    Via The Motley Fool
    News headline image
    Should You Buy Moderna Right Now? ↗
    Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough. 
    Via The Motley Fool
    Topics Bonds
    News headline image
    Wellgistics And DataVault Team Up To Transform Prescription Tracking ↗
    DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market. 
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall ↗
    Don't try to catch a falling surgical knife. 
    Via The Motley Fool
    Topics Government
    News headline image
    Dow Jumps More Than 500 Points Ahead Of Earnings: Investor Fear Eases, Greed Index Remains In 'Fear' Zone ↗
    U.S. stocks rise on Monday, with the Dow up 500+ points. Moderna and Cleveland-Cliffs report gains. Most S&P sectors close higher, with Fear & Greed Index at 30.3. 
    Via Benzinga
    Topics Stocks
    News headline image
    Small Caps Rally As Credit Fears Ease, Gold Rebounds To $4,350: What's Moving Markets Monday? ↗
    Via Benzinga
    News headline image
    What's going on in today's session: S&P500 movers ↗
    Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
    Via Chartmill
    News headline image
    Stay informed with the top movers within the S&P500 index on Monday. ↗
    Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
    Via Chartmill
    News headline image
    Stock Market Today: S&P 500, Nasdaq, Dow Jones Futures Rise— Micron, Bitmine, Coinbase In Focus ↗
    U.S. stock futures rose on Monday following Friday’s advances. Futures of major benchmark indices were higher. 
    Via Benzinga
    Topics Stocks
    News headline image
    2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
    Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
    Via StockStory
    News headline image
    Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
    The biotechnology sector is currently experiencing a significant surge in investor attention, characterized by a blend of cautious optimism and strategic focus. As of October 2025, this heightened... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    < Previous 1 2
    ...
    9 10 11 12 13 14 15 16 17
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.